Acute Pericarditis After Percutaneous Coronary Intervention
Abstract
Pericarditis may be a complication of percutaneous coronary intervention (PCI), and should be considered as a differential for persistent chest pain following a PCI. In this report, we present a male in his 60s, who developed pericarditis after a primary PCI for an anterior ST elevation myocardial infarction (STEMI). He had an uncomplicated PCI to left anterior descending artery, and was discharged as per standard procedure 48 hours post-procedure. On that same evening, the patient re-presented to hospital with different chest pain and fever. Electrocardiogram (ECG) revealed anterior ST elevation. A provisional diagnosis of pericarditis was made in view of elevated inflammatory markers, a recent Mycoplasma infection with fevers, positron emission tomography-computed tomography (PET-CT) findings, as well as pericardial chest pain. A three-month course of colchicine was initiated. Two weeks after discharge, he was readmitted with non-resolving fevers. Echocardiogram (ECHO) and CT thorax revealed a 26mm pericardial effusion. This was not drained, as he had no signs of tamponade. He was treated as possible infective pericarditis with intravenous (IV) teicoplanin and piperacillin-tazobactam, which was stepped down to oral co-trimoxazole on discharge. Three weeks after completing the oral antibiotics, he was re-admitted again with fevers and chest pain. He was restarted on antibiotics and heart failure medications were up-titrated. He was continued on colchicine and started on…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.